电子健康数据预测动脉瘤性蛛网膜下腔出血后的结局
该单中心回顾性队列纳入2011–2016年153例动脉瘤性蛛网膜下腔出血患者,评估473个预测变量,结局为出院GOS。多变量分析中,死亡预测模型AUC 0.9198,纳入APACHE II评分、GCS、白细胞计数、平均动脉压、血清葡萄糖方差、颅内压和血清钠;死亡/依赖 vs 独立(GOS 4–5)预测模型AUC 0.9456,纳入左乙拉西坦、机械通气、白细胞计数、心率、ICP方差、GCS、APACHE II和癫痫样放电。多分类模型纳入GCS、入院APACHE II、周期性放电、拉考沙胺和再出血,预测差或良好结局准确率超过80%,预测中间结局准确率超过70%。作者认为早期生理数据变异度可能作为早期目标导向治疗靶点,ICP、血糖和脑电图模式等电子可提取特征应考虑纳入疾病严重度和风险分层评分。
要点
- 单中心回顾性队列153例aSAH,多数出院GOS为3分。
- 死亡预测模型AUC 0.9198,纳入APACHE II、GCS、WBC、MAP、血糖方差、ICP、血钠。
- 死亡/依赖 vs 独立预测模型AUC 0.9456,纳入左乙拉西坦、机械通气、WBC、心率、ICP方差、GCS、APACHE II、癫痫样放电。
- 多分类模型纳入GCS、入院APACHE II、周期性放电、拉考沙胺、再出血,预测差或良好结局准确率超80%,中间结局超70%。
- 作者认为早期生理数据变异度可能作为早期目标导向治疗靶点,ICP、血糖、脑电图模式应考虑纳入风险分层评分。
适用人群与场景
- 2011–2016年单中心收治的动脉瘤性蛛网膜下腔出血患者,纳入153例。
研究设计与关键结果
- 研究类型:单中心回顾性队列研究,纳入153例aSAH患者,评估473个预测变量,结局为出院GOS。
- 死亡预测模型AUC 0.9198,预测变量包括APACHE II评分、GCS、白细胞计数、平均动脉压、血清葡萄糖方差、颅内压和血清钠。
- 死亡/依赖 vs 独立(GOS 4–5)预测模型AUC 0.9456,预测变量包括左乙拉西坦、机械通气、白细胞计数、心率、ICP方差、GCS、APACHE II和癫痫样放电。
- 多分类预测模型选择GCS、入院APACHE II、周期性放电、拉考沙胺和再出血为显著预测因子,预测差或良好结局准确率超过80%,预测中间结局准确率超过70%。
- 多数患者出院时GOS为3分。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为早期生理数据变异度可影响患者结局,可能作为早期目标导向治疗靶点。
- 作者认为ICP、血糖水平和脑电图模式等电子可提取特征应考虑纳入疾病严重度和风险分层评分。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUD: Using electronic health data, we sought to identify clinical and physiological parameters that in combination predict neurologic outcomes after aneurysmal subarachnoid hemorrhage (aSAH).
METHODS: We conducted a single-center retrospective cohort study of patients admitted with aSAH between 2011 and 2016. A set of 473 predictor variables was evaluated. Our outcome measure was discharge Glasgow Outcome Scale (GOS). For laboratory and physiological data, we computed the minimum, maximum, median, and variance for the first three admission days. We created a penalized logistic regression model to determine predictors of outcome and a multivariate multilevel prediction model to predict poor (GOS 1-2), intermediate (GOS 3), or good (GOS 4-5) outcomes.
RESULTS: One hundred and fifty-three patients met inclusion criteria; most were discharged with a GOS of 3. Multivariate analysis predictors of mortality (AUC 0.9198) included APACHE II score, Glasgow Come Scale (GCS), white blood cell (WBC) count, mean arterial pressure, variance of serum glucose, intracranial pressure (ICP), and serum sodium. Predictors of death/dependence versus independence (GOS 4-5)(AUC 0.9456) were levetiracetam, mechanical ventilation, WBC count, heart rate, ICP variance, GCS, APACHE II, and epileptiform discharges. The multiclass prediction model selected GCS, admission APACHE II, periodic discharges, lacosamide, and rebleeding as significant predictors; model performance exceeded 80% accuracy in predicting poor or good outcome and exceeded 70% accuracy for predicting intermediate outcome.
CONCLUSIONS: Variance in early physiologic data can impact patient outcomes and may serve as targets for early goal-directed therapy. Electronically retrievable features such as ICP, glucose levels, and electroencephalography patterns should be considered in disease severity and risk stratification scores.
参考来源
- Zafar SF, Postma EN, Biswal S, et al. Electronic Health Data Predict Outcomes After Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2018. PMID: 28983801. doi:10.1007/s12028-017-0466-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。